Study of comparison between presence of dysnatremia and severity of COVID 19
Lung India
; 39(SUPPL 1):S152-S153, 2022.
Article
in English
| EMBASE | ID: covidwho-1857702
ABSTRACT
Background:
Patients with Coronavirus disease 2019 (COVID-19), caused by SARS-COV2 infection, can develop a potentially fatal rapid-onset pneumonia. In fact, mortality in patients hospitalized with COVID-19 can be as high as 20.3-27.9%.This study aimed to determine whether hyponatremia and hypernatremia are associated with a poor prognosis in patients admitted with COVID-19.Methods:
Retrospective study conducted in Department of Respiratory Medicine, KIMS hospital and Research center, Bangalore , with a sample size of 1000 COVID 19 patients.Results:
According to the above study, dysnatremia was found more in Category-C COVID19 patients, than cat A and Cat B, with 48.1% of patients in Cat C having dysnatremia, 29.9 % of Cat B and 24.3%of Cat C. In dysnatremia, hyponatremia was found was predominant among patients of Cat C COVID 19.Conclusion:
Patients admitted with COVID 19, have risk of dysnatremia with increasing severity of the disease and it has significant impact on the morbidity and outcome of the patients.
Search on Google
Collection:
Databases of international organizations
Database:
EMBASE
Type of study:
Prognostic study
Language:
English
Journal:
Lung India
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS